NCT01962623

Brief Summary

The purpose of this study is to determine the feasibility and acceptability of utilizing an adapted form (i.e. IPT-MBD) of a psychosocial intervention, Interpersonal Psychotherapy for Depressed Adolescents, for youth with severe mood dysregulation (SMD) or disruptive mood dysregulation disorder (DMDD). The investigators hypothesize that retention rates will be \>80%, satisfaction scores will average 6 (high) on a 7 point satisfaction scale, and that youth who receive the IPT intervention will have overall improvement in SMD/DMDD symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 14, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

May 24, 2017

Status Verified

May 1, 2017

Enrollment Period

2.2 years

First QC Date

October 10, 2013

Last Update Submit

May 22, 2017

Conditions

Keywords

Severe Mood DysregulationMood DisordersIrritabilityDisruptive Mood Dysregulation DisorderInterpersonal Psychotherapy

Outcome Measures

Primary Outcomes (1)

  • Retention rate

    To describe/assess feasibility of IPT-MBD, investigators will look at ease of recruitment and retention rate goal of at least 80%. Investigators will collect data on the number of subjects recruited, enrolled, and who followed the protocol for 24 weeks. Investigators will comment on adherence to the overall study, as well as to specific treatment visits.

    24 weeks

Secondary Outcomes (2)

  • Clinical Global Impressions Scale for SMD/DMDD (CGI-SMD/DMDD)

    24 weeks

  • Satisfaction

    24 weeks

Study Arms (2)

Treatment as Usual (TAU)

ACTIVE COMPARATOR

Participants who are not randomly assigned to the IPT-MBD group will continue with treatment at usual, which is considered routine care.

Other: IPT-MBD

IPT-MBD

OTHER

Weekly Interpersonal Therapy for SMD/DMDD (IPT-MBD) sessions, which emphasizes building skills in managing relationships, helping with problem solving, strengthening communication skills and other skills.

Other: IPT-MBD

Interventions

IPT-MBDOTHER

IPT-MBD is a modified form of Interpersonal Psychotherapy for Depressed Adolescents (IPT-A), which emphasizes building skills in managing relationships, helping with problem solving, and strengthening communication skills.

Also known as: IPT for Mood and Behavior Dysregulation
IPT-MBDTreatment as Usual (TAU)

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Male and female subjects, ages 12 to 17 years, who meet criteria for severe mood dysregulation (SMD) as defined by NIMH criteria or for disruptive mood dysregulation disorder (DMDD).
  • Subject has an estimated IQ \>70 on the Kaufman Brief Intelligence Test (KBIT-
  • Subjects will have continuously resided with a legal guardian who has known the adolescent well for at least one year before study entry and is legally able to sign the consent form.
  • Children's Global Assessment Scale (CGAS) ≤ 60
  • CGI-S (SMD) ≥ 4
  • Participant and guardian must agree to have therapy sessions audiotaped for training purposes.

You may not qualify if:

  • Subject poses a significant risk for dangerousness to self or others. Risk will be determined by clinical history, clinical diagnostic interview and KSADS-PL interview of parent and patient by clinician.
  • Subject suffers from a concomitant medical or psychiatric comorbidity that makes this study protocol inadvisable (either the treatment is contraindicated or the disorder is not the primary focus of treatment).
  • Subject meets DSM-IV criteria for current alcohol or substance dependence or current use (defined as the past 4 weeks).
  • Primary caretaker does not speak English or is not capable of completing study measures.
  • Pregnant females.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins University Bayview Medical Center

Baltimore, Maryland, 21224, United States

Location

MeSH Terms

Conditions

Mood Disorders

Interventions

adenylate isopentenyltransferase

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Leslie Miller, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 10, 2013

First Posted

October 14, 2013

Study Start

August 1, 2013

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

May 24, 2017

Record last verified: 2017-05

Locations